Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KLA Corp. (KLAC) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

KLA Corp. vs Vir Biotechnology Inc. Common Stock — how do they compare? KLA Corp. trades at $173.88 (market cap $240.12B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: KLA Corp. is far larger — about 133.4× Vir Biotechnology Inc. Common Stock's market cap, and KLA Corp. pays a 0.5% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold KLA Corp. for 60 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

KLACVIR
Market Cap
$240.12B$1.80B
Volume
10,439,4041,782,836
Sector
TechnologyHealth
52-Week High
$301.71$11.78
52-Week Low
$108.70$5.12
Typical Hold Time
60 Days0 Days
Enterprise Value
$241.37B$1.36B
Dividend Yield
0.5%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KLA Corp.

KLA Corporation (KLAC) trades at $178.81, down 5.95% on the day, amid a broader tech selloff. The stock maintains a bullish technical signal, with strong fundamentals including a 35.57% net income margin and consistent earnings beats. Revenue reached $12.16B in 2025, with a robust backlog of $12.57B driven by AI demand, positioning the company for growth in semiconductor equipment.

The outlook remains positive with a consensus price target of $223.88, implying significant upside. Risks include competitive pressures from Applied Materials and ASML, and sensitivity to semiconductor capex cycles. Analyst sentiment is strongly bullish, with 28 buy ratings, supporting a favorable long-term investment case despite near-term volatility.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KLAC
100% Buy0% Sell
Avg holding period · 60 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About KLA Corp.

KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.

Read more on KLAC →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →